1 TCAs were the mainstay of therapy for fibromyalgia for many years
Researched effects In a diet-induced-obese mouse study (Neelakantan et al., Biochemical Pharmacology, 2018), subcutaneous 5-Amino-1MQ (20 mg/kg, three times daily, roughly 11 days) produced about 5.1% body-weight loss versus continued weight gain in untreated controls, roughly 35% less epididymal white fat mass, smaller adipocytes, lower plasma cholesterol, and improved glucose tolerance, with no reported change in food intake and no observed adverse effects in the mice
This concern warrants appropriate screening and consideration of personal cancer risk factors before use
More severe cases might take longer and full recovery might not be possible
The correlation between vitamin B12 serum levels and migraine: a case-control study